Cargando…
P350 EFFECTS OF ATOPIC DISEASE ON DISEASE SEVERITY IN COVID-19
Autores principales: | Timberlake, D., Narayanan, D., Ogbogu, P., Raveendran, R., Prince, B., Scherzer, R., Porter, K., Grayson, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661961/ http://dx.doi.org/10.1016/j.anai.2020.08.147 |
Ejemplares similares
-
Severity of COVID-19 in hospitalized patients with and without atopic disease()
por: Timberlake, Dylan T., et al.
Publicado: (2021) -
COVID-19 Severity in Hospitalized Pediatric Patients with Atopic Disease
por: Timberlake, Dylan, et al.
Publicado: (2021) -
COVID-19, health disparities, and what the allergist-immunologist can do
por: Ogbogu, Princess U., et al.
Publicado: (2021) -
A050 THE IMPACT OF COVID-19 AND DISEASE CONTROL MEASURES ON PEDIATRIC FOOD ALLERGY PARENTS/CAREGIVERS AND PATIENTS
por: Warren, C., et al.
Publicado: (2020) -
Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19
por: Zimilover, Adam, et al.
Publicado: (2022)